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We read with interest the paper by Vlooswijk et al.
reporting a retrospective cohort study of SUDEP
amongst attendees of a tertiary referral centre
for epilepsy in the Netherlands.1 The authors draw
conclusions which are, however, unsubstantiated
due to methodological problems. It is not entirely
clear how the authors established the survivorship
of all patients who had attended the centre over the
study period. Failure to establish survivor status for
all attendees may introduce bias and cause under-
estimation of death rates. The number of patient-
years is a crucial number in this type of study and
somehow, in this paper, this is not provided.
Furthermore the choice of those dying of non-
SUDEP deaths as controls is difficult to justify as
this may introduce further bias in the estimation of
risk factors. As noted by others, clinical variables
may be more usefully explored in studies using
living controls.2
It is stated that the SUDEP rate obtained was 1.24
per 1000 patient-years, but one struggles to under-
stand how this number was derived. After exclu-
sions, 29 SUDEP cases (of whom only 5 had post-
mortem examination) remained; this would suggest
that about 23,400 patient-years were included; this
is very similar to that which would be derived from
the mean number of patients attending each year,
which would be appropriate if this was a total
population study. This study is, however, of a cohort
and therefore accurate patient-years of follow up
(rather than average number) are required as well
as adequate confirmation of the survivor status of all1059-1311/$ — see front matter # 2007 British Epilepsy Association
doi:10.1016/j.seizure.2007.06.002patients in the cohort. This procedure was not
reported in this study.
It has been noted that risk factors for SUDEP
depend on the type of controls used for comparison,2
and this is exemplified in this study. As the controls
had died, and of causes other than SUDEP, it is not
surprising that their age at death was higher than in
cases. Duration of epilepsy was found to be shorter in
SUDEP patients than in controls but, as noted by the
authors in thediscussion, this canbeattributed to the
difference in age at death. It is surprising that one-
sided statistical tests were used in these analyses;
two-sided tests would be more appropriate.
For the above reasons we do not feel that this
study as presented provides reliable incidence data
for SUDEP; neither does it provide any confirmation
for clinical risk factors for SUDEP. Studies using
appropriate methodology are still warranted to
establish the incidence and risk factors for SUDEP
in the population attending tertiary referral centres
in the Netherlands.References
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